Enduralife + Latitude + HeartLogic = 360CRT


In a pandemic situation, it is more relevant than ever to emphasise the importance of keeping patients out of hospital.

At Boston Scientific we are offering healthcare professionals 360-degree clinical care including a complete package of superior HF diagnostics, industry leading battery longevity and efficient remote management systems. Through these solutions, and together with you, we aim to reduce the number of hospitalisations and unnecessary hospital visits

The COVID-19 pandemic has created
challenges for everyone – especially
healthcare professionals.

We have adapted quickly to stay with you through these times, and we will continue todo so as we discover the “new normal” together. Whilst we know our support may need to continuously evolve, we are here to meet your individual case needs now.

 


 

66% of patients are nervous or very nervous about visiting their HCP
are nervous or very nervous
about visiting their HCP
90% of patients seek reassurance that their HCP office/hospital is clean, safe and taking precautions
seek reassurance that their HCP office/hospital is clean, safe and taking precautions
85% of patients are interacting with their HCP less frequently than before COVID-19
are interacting with their HCP less frequently than before COVID-19
Source: Boston Scientific May 2020 US Patient Research

 


 

Focus Enduralife

 

LONGEVITY


Longevity has an impact on the patient’s life by requiring fewer replacements:

  • Minimising risk of infection and complication
  • Reducing therapy costs
  • Improving patients’ QoL

Boston Scientific introduced EnduraLife™ Battery Technology in 2007 and it is regarded as a proven technology, validated by nine studies published from 2013 onwards.1-9 Boston Scientific brings the longest-lasting devices on the market.10-11

Outperforming the Competition

EnduraLife™ Battery Technology has the largest usable battery capacity vs. Medtronic and Abbott.12

Outperforming competition
High battery capacity is nearly 2x the usable battery capacity of Medtronic CRT-Ds13

Discover more on EnduraLife Battery Technology

DISCOVER MORE ON DEVICE LONGEVITY

 


 

Discover Boston Scientific Patient Management solutions

 

REMOTE PATIENT MANAGEMENT


Remote device monitoring is more relevant and useful than ever during the COVID-19 pandemic. It will help you:

  • Identify clinical events and device anomalies in patients with cardiac implantable defibrillators who's in-person visit was canceled.
  • Allow physicians to monitor disease progression remotely and to modify patients’ treatment appropriately (except for programming changes).
  • When patients feel more empowered in the remote monitoring process, they will become more invested in improving their health. Thus, we should feel confident to use remote device monitoring for patients with cardiac implantable defibrillators during the COVID-19 pandemic.14

In the context of the Covid-19 pandemic, leveraging remote patient monitoring technology will help eliminate unnecessary patient contact, while reducing the burden on in-clinic follow-up.

In the context of the Covid-19 pandemic, leveraging remote patient monitoring technology will help eliminate unnecessary patient contact, while reducing the  burden on in-clinic follow-up.
  • "Is recommended that HF patients are enrolled in a multidisciplinary HF management programme to reduce the risk of HF hospitalisation and mortality."15

  • "Remote device management is recommended to reduce number of in-office follow-up in patients."15


2021 ESC Guidelines16,17 for the management of chronic Heart Failure and implantable devices. Recommendations have now the highest level of evidence: Class 1, level of evidence A

 

 

Discover Boston Scientific Patient Management solutions

DISCOVER MORE ON REMOTE PATIENT MANAGEMENT PORTFOLIO

 


 

Discover how HeartLogic™ can help you in your daily practice

 

HEART FAILURE DIAGNOSTIC


In the COVID-19 pandemic, and beyond, HeartLogic offers a personalised, remote heart failure diagnostic and monitoring solution. Using multiple, novel physiologic sensors with high sensitivity and low-alert burden, it’s validated to provide weeks of advance notice for detecting early signs of worsening heart failure.

Physician Perspectives on the HeartLogic™ Heart Failure Diagnostic


HeartLogic is clinically validated to provide weeks of advance notice for detecting early signs of worseningheart failure18

70% Sensitivity in detecting heart failures events
SENSITIVITY
in detecting heart failure events18
Median of 34 days advance notice of heart failure wersening
DAYS ADVANCE NOTICE
of heart failure worsening18
<2 total alerts per patient per year
TOTAL ALERTS
per patient per year18


Integration into clinical practice

In the MANAGE-HF Phase 1 Study19, HeartLogic is associated with:

  • a 67% reduction in HF hospitalisation rate
  • A reduction of N-terminal pro b-type natriuretic peptide (NTproBNP) levels
More rapid recovery of HeartLogic index
MORE RAPID RECOVERY
of HeartLogic index
Lower NTproBNP Levels
LOWER
NTproBNP Levels
67% reduction in Hospitalisation Associated with HeartLogic
67% REDUCTION
in Hospitalisation Associated with HeartLogic

 

Discover how HeartLogic™ can help you in your daily practice

DISCOVER MORE ON HEART FAILURE DIAGNOSTIC

 

Top